George Georgiou | Professor
The University of Texas At Austin

George Georgiou, Professor, The University of Texas At Austin

Since 2009 the Georgiou laboratory has been focused on the discovery and development of protein therapeutics and on the analysis of adaptive immune responses.

Current Projects include: Engineering and preclinical/clinical development of human enzyme therapeutics for the treatment of solid tumors and leukemias.
Development of methods for the molecular-level identification of the human antibody repertoire in blood and in secretions.

  1. Analysis of the antibody repertoire elicited by viral infection (e.g. HIV-1) and vaccination to aid the development of more efficient vaccination strategies.
  2. Engineering of antibody therapeutics displaying enhanced ability to recruit cytotoxic leukocytes and blood proteins (complement) for the effective clearance of pathogens.
Earlier work by the Georgiou lab focused on redox homeostasis and protein biogenesis in bacteria and on the development of platform technologies for protein expression and engineering. These studies led to a number of mechanistic advances that are being used commercially for therapeutic protein manufacturing and protein engineering.

Dr Georgiou is the co-inventor of 29 issued patents and 52 pending US patents and, notably, 16 different technology suites (comprising either one or multiple patents) that have been licensed to major pharmaceutical and biotechnology companies.

Appearances:



April 16 Day 2 - 10 Co-conferences @ 15:40

Analysis of the antibody repertoire elicited by viral infection and vaccination to aid the development of more efficient vaccines

last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071